Navigation Links
ViroPharma Incorporated Reports Second Quarter 2009 Financial Results
Date:7/29/2009

me period in 2008. GAAP net loss per share for the six months ended June 30, 2009 was $0.56 per share, basic and diluted, compared to a GAAP net income per share of $0.56, basic, and $0.51, diluted, for the same period in 2008.

Non-GAAP adjusted net income in the three and six months ended June 30, 2009 was $34.5 million and $46.0 million, respectively, compared to $28.9 million and $51.0 million, respectively, for the same periods in 2008.

The primary drivers of the GAAP net loss in the six months ended June 30, 2009 was the impairment of goodwill for $65.1 million, offset by the gain on our repurchase of our senior convertible notes of $9.1 million. Contributing to this loss were launch costs for Cinryze, increased expenses relating to the development of our product pipeline, and the increase in amortization expense. GAAP net income decreased for the second quarter of 2009 as compared to 2008 due to a decrease in Vancocin sales, increased SG&A costs related to the launch of Cinryze, increased amortization and lower interest income, partially offset by Cinryze sales.

Effective January 1, 2009, the Company adopted Financial Accounting Standards Board's Staff Position No. APB 14-1, "Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement)" ("FSP APB 14-1"), which changed the method of accounting for the Company's convertible notes. The Company revised its previously reported financial statements to apply this change in accounting to prior periods. Under this new accounting method, the Company's EPS and net (loss) income calculated in accordance with GAAP have been reduced as a result of recognizing incremental non-cash interest expense. In connection with adopting FSP APB 14-1, the Company recorded $1.7 million and $2.0 million of additional non-cash interest expense in the three months ended June 30, 2009 and 2008, respectively, and $3
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. ViroPharma to Release 2009 Second Quarter Financial Results on July 29, 2009
2. ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
3. ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products
4. ViroPharma to Present at Two May Healthcare Conferences
5. ViroPharma to Present at the Cowen & Company 29th Annual Healthcare Conference
6. ViroPharma to Host Investor Teach-In Educational Symposium on Hereditary Angioedema
7. ViroPharma to Release 2008 Fourth Quarter and Full Year Financial Results on February 24, 2009
8. ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
9. ViroPharma to Present at the 27th Annual J.P. Morgan Healthcare Conference
10. ViroPharma Provides Update on Vancocin(R)
11. ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... From first-hand experience, Matthew O'Farrell knows all about ... can be treated. , A medically retired Army veteran, ... platoon sustained multiple attacks resulting in five casualties. After ... PTSD and honorably discharged from the Army. , “I ... myself from my friends and family,” recalled O’Farrell, who ...
(Date:9/23/2014)... By Karen Pallarito ... -- Imagine if doctors and hospitals got paid for providing ... consumers had better data for making informed health choices. ... health system is headed. The report, from the IMS ... of change" -- recent events expected to alter the delivery ...
(Date:9/23/2014)... 2014 What information do patients ... Quality Forum (NQF) released a report ( http://bit.ly/1DwekE9 ... an infographic ( http://bit.ly/1tX3lzA ) resulting from an ... how patients define affordability, and what information and ... best possible healthcare at the lowest possible cost. ...
(Date:9/23/2014)... A recent Oregon survey about an exercise DVD that ... routine of elementary school students found it had a ... and offered clear advantages for overly sedentary educational programs. ... produced by the Healthy Youth Program of the Linus ... nationally. , Brain Breaks leads children in 5-7 minute ...
(Date:9/23/2014)... 23, 2014 Trevera provides multiple ... Included are Oracle Managed Services , Oracle ... all versions of Oracle E-Business Databases and ... , Trevera has announced a significant enhancement to ... help with their software technology management, project management, ...
Breaking Medicine News(10 mins):Health News:Virtual Reality software to help treat PTSD 2Health News:Virtual Reality software to help treat PTSD 3Health News:Report Identifies Game Changers for U.S. Health Care 2Health News:Report Identifies Game Changers for U.S. Health Care 3Health News:Finding Affordable Care: Asking the Right Question is Key 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 3Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3
... Swaroop Rani Nehru Hospital (SRN hospital) has resumed function, ... //. Two old dialysis machines have been repaired and ... ,Following inspection by the Medical Council of India ... machines. The patients are being charged for Rs 500 ...
... study published in PLoS Pathogens says that researchers have ... bacterium, which belongs to the family Acetobacteraceae is a ... the vinegar-making industry. ,The bacterium was identified ... is a rare genetic disorder that compromises the immune ...
... For the first time researchers have studied deeply about fat ... in the heart .Research has now revealed that these Fat ... of heart disease. University of Iowa researchers have revealed that ... ,Fat cells, once upon a time, were thought to have ...
... vegetables in your diet helps you to have fewer wrinkles ... // ,People with a normal diet can make ... red paprika in their meals, German magazine The Dermatologist said ... oxygen molecules - are a major factor in premature skin ...
... to a new study, lack of sleep in children, ... the University of Laval's faculty of medicine studied 422 ... the weight, height, and waist size of each participant. ... lifestyle and socio-economic status through phone interviews with their ...
... with cancer are interested in finding about latest treatments ... support //, reveals a new cancer study. Clive Seale, ... that cancer reaction is linked to gender. The findings ... to cancer support groups that help cancer patients. ...
Cached Medicine News:Health News:Fat cells lethally connected to heart disease 2Health News:Gender Difference In Reaction To Cancer 2
(Date:9/23/2014)...  SI-BONE, Inc., a medical device company that pioneered ... a minimally invasive surgical (MIS) device indicated for fusion ... U.S. Patent and Trademark Office has awarded the company ... fixation and fusion of bone.  This newly issued patent ... may be placed from one bone across a joint ...
(Date:9/23/2014)... NEW YORK , September 23, 2014 ... nouvelle solution Face2Gene améliorée lors d,une série ... http://www.fdna.com ), pionnier dans le domaine de ... exposera sa solution au stand n° 1035 lors ... à San Diego , ...
(Date:9/23/2014)... , Sept. 23, 2014   MedNet Solutions , a ... systems, is pleased to announce that it will once again ... Management (SCDM) Annual Conference, to be held this year from ... , Nevada. MedNet team members, in conjunction with representatives from ... who will also be in attendance, will be providing demonstrations ...
Breaking Medicine Technology:SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 2SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 3FDNA exposera sa solution Face2Gene intégrée en ligne avec London Medical Databases (LMD) à l'ASHG 2014 2FDNA exposera sa solution Face2Gene intégrée en ligne avec London Medical Databases (LMD) à l'ASHG 2014 3MedNet Solutions - Proud To Sponsor The SCDM 2014 Annual Conference 2
... facilitates stomal insertion., ,Adult TTS™ Adjustable ... trach tie, disconnect wedge, and obturator/introducer device., ... are intended for temporary use until the ... be obtained. Not for home care use. ...
... Lo-Profile™ tracheostomy tube is cosmetically pleasing ... styles of inner cannula come with ... cannula and a 15 mm ISO ... The semi-reusable inner cannula may be ...
... mm ISO termination for easy ventilator circuit ... place. , ,Clearly the softer choice ... , ,The Portex® flexible disposable inner ... polyvinyl chloride, providing a softer and more ...
... TRACH CARE Dual Lumen, allows ... the patient end of the ... Swivel Elbow and Direction Tip ... Offers multiple tracheostomy sizes, French ...
Medicine Products: